| 000 | 00890 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250518093324.0 | ||
| 264 | 0 | _c20210108 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a2376-1032 | ||
| 024 | 7 |
_a10.18553/jmcp.2020.26.4.407 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWatkins, John B | |
| 245 | 0 | 0 |
_aAugmenting Cost-Effectiveness Analysis Will Not Improve Affordability. _h[electronic resource] |
| 260 |
_bJournal of managed care & specialty pharmacy _c04 2020 |
||
| 300 |
_a407-408 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Economic |
| 700 | 1 | _aTsiao, Emily G | |
| 773 | 0 |
_tJournal of managed care & specialty pharmacy _gvol. 26 _gno. 4 _gp. 407-408 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18553/jmcp.2020.26.4.407 _zAvailable from publisher's website |
| 999 |
_c30791489 _d30791489 |
||